Show simple item record

FieldValueLanguage
dc.contributor.authorSullivan, Richard
dc.date.accessioned2017-10-26
dc.date.available2017-10-26
dc.date.issued2017-10-26
dc.identifier.urihttp://hdl.handle.net/2123/17325
dc.descriptionSeminar presentation + oral recordingen_AU
dc.description.abstractIn this lecture we will explore the evidence for the divergences and deficits, investor policy towards pricing and what determines price (such as power relationships), the conflicted relationship between the research communities, patient organisations, the media, regulatory authorities and pharmaceutical sector, and the data around declining value and affordability. What solutions can and should be imposed at both national and supra-national levels?en_AU
dc.description.sponsorshipCancer Council Australiaen_AU
dc.language.isoen_AUen_AU
dc.subjectcanceren_AU
dc.subjectsystems of careen_AU
dc.subjectoutcomesen_AU
dc.subjecthealthcareen_AU
dc.subjectmedicineen_AU
dc.subjectnew technologyen_AU
dc.titleCan we cure the price problem for new cancer technologies?en_AU
dc.typePresentationen_AU
dc.contributor.departmentMenzies Centre for Health Policyen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.